hyperkalemia
Showing 1 - 25 of 74
Hyperkalemia, Potassium Imbalance, Electrolyte Imbalance Trial in Seeb (Insulin regular, Dextrose 50, salbutamol)
Not yet recruiting
- Hyperkalemia
- +3 more
- Insulin regular
- +2 more
-
Seeb, Muscat, OmanSultan Qaboos University hospital
Sep 11, 2023
Hyperkalemia Trial in Alexandria (sodium zirconium cyclosilicate (SZC), sodium polystyrene sulfonate)
Not yet recruiting
- Hyperkalemia
- sodium zirconium cyclosilicate (SZC)
- sodium polystyrene sulfonate
-
Alexandria, EgyptFaculty of Medicine, Aexandria University
Sep 7, 2023
Dietary Fiber and Hyperkalemia in Dialysis Patients
Completed
- Hyperkalemia
- Hemolysis
- dietary fiber
-
Jinan, Shandong, ChinaQianfoshan Hospital
May 8, 2023
Hyperkalemia Trial in Ranica (Veltassa Oral Powder Product, Placebo)
Not yet recruiting
- Hyperkalemia
- Veltassa Oral Powder Product
- Placebo
-
Ranica, BG, ItalyCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Mar 29, 2023
Hyperkalemia Trial in Worldwide (Sodium Zirconium Cyclosilicate (SZC), SZC Placebo)
Recruiting
- Hyperkalemia
- Sodium Zirconium Cyclosilicate (SZC)
- SZC Placebo
-
Huntsville, Alabama
- +355 more
Feb 1, 2023
Tracking Treatment Pathways in Adult Patients With Hyperkalemia.
Recruiting
- Hyperkalemia
-
La Jolla, California
- +105 more
Jan 19, 2023
Chronic Kidney Disease stage4, Chronic Kidney Disease Stage 5, Hyperkalemia Trial in Stockholm (sodium zirconium cyclosilicate
Recruiting
- Chronic Kidney Disease stage4
- +2 more
- sodium zirconium cyclosilicate and healthy diet
-
Stockholm, SwedenKarolinska Institutet
Jan 16, 2023
Renal Insufficiency, Chronic, Hyperkalemia Trial in Worldwide (Sodium Zirconium Cyclosilicate (SZC), Placebo, Lisinopril)
Recruiting
- Renal Insufficiency, Chronic
- Hyperkalemia
- Sodium Zirconium Cyclosilicate (SZC)
- +4 more
-
Tucson, Arizona
- +281 more
Jan 10, 2023
Hyperkalemia, Hypokalemia Trial in Taipei (AI-enabled ECG-based Screening Tool)
Recruiting
- Hyperkalemia
- Hypokalemia
- AI-enabled ECG-based Screening Tool
-
Taipei, TaiwanNational Defense Medical Center
Nov 2, 2022
Hyperkalemia Trial in China, India (Sodium Zirconium Cyclosilicate 5g, Sodium Zirconium Cyclosilicate 10g, Placebo)
Completed
- Hyperkalemia
- Sodium Zirconium Cyclosilicate 5g
- +2 more
-
Beijing, China
- +31 more
Oct 11, 2022
Hyperkalemia, Renal Insufficiency, Chronic Trial in China (Patiromer Powder for Oral Suspension (Part A), Placebo (Part B),
Recruiting
- Hyperkalemia
- Renal Insufficiency, Chronic
- Patiromer Powder for Oral Suspension (Part A)
- +2 more
-
Hefei, Anhui, China
- +21 more
Sep 15, 2022
Hyperkalemia Trial in United States (LOKELMA 5 GM Powder for Oral Suspension)
Recruiting
- Hyperkalemia
- LOKELMA 5 GM Powder for Oral Suspension
-
La Jolla, California
- +4 more
Sep 7, 2022
Recurrence and Treatment in Haemodialysis
Completed
- Hyperkalemia
- +2 more
- observational study
-
Beijing, Beijing, China
- +11 more
Aug 12, 2022
Hospitalized Heart Failure With Different Serum Potassium Levels
Completed
- Hyperkalemia
- +2 more
-
Shanghai, Shanghai, ChinaResearch Site
Aug 12, 2022
Long-term Management of Hyperkalemia in Chronic Kidney Disease
Recruiting
- Hyperkalemia
-
Kasugai, Aichi, Japan
- +25 more
Aug 10, 2022
Detect Hyperkalemia Using Smartphone-enabled Electrocardiogram
Enrolling by invitation
- Hyperkalemia
-
Rochester, MinnesotaMayo Clinic
Jun 29, 2022
Hyperkalemia, End Stage Renal Disease Trial in Durham (Patiromer Oral Powder Product)
Enrolling by invitation
- Hyperkalemia
- End Stage Renal Disease
- Patiromer Oral Powder Product
-
Durham, North CarolinaDaVita Dialysis Sites
Jun 10, 2022
Heart Failure, Hyperkalemia Trial in Worldwide
Recruiting
- Heart Failure
- Hyperkalemia
-
Little Rock, Arkansas
- +84 more
Jun 2, 2022
Hyperkalemia Trial in United States (Patiromer Powder for Oral Suspension [Veltassa], Placebo)
Recruiting
- Hyperkalemia
- Patiromer Powder for Oral Suspension [Veltassa]
- Placebo
-
Stanford, California
- +14 more
May 25, 2022
Sodium Zirconium Cyclosilicate, Hyperkalemia, Hyperparathyroidism, Secondary Trial (Sodium zirconium cyclosilicate)
Completed
- Sodium Zirconium Cyclosilicate
- +2 more
- Sodium zirconium cyclosilicate
- (no location specified)
May 16, 2022
CKD, Diabetes, Type 2, Hyperkalemia Trial in London (Sodium Zirconium Cyclosilicate, Placebo)
Not yet recruiting
- CKD
- +2 more
- Sodium Zirconium Cyclosilicate
- Placebo
-
London, Uk, United KingdomKieran Mccafferty
Mar 17, 2022
Chronic Kidney Diseases, Heart Failure With Reduced Ejection Fraction, Hyperkalemia Trial in London (Lokelma Oral Product)
Recruiting
- Chronic Kidney Diseases
- +4 more
- Lokelma Oral Product
-
London, United KingdomSt Georges, University of London
Feb 16, 2022